Enterprise Value
539.2M
Cash
168.4M
Avg Qtr Burn
-19.01M
Short % of Float
34.74%
Insider Ownership
6.04%
Institutional Own.
28.98%
Qtr Updated
06/30/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Simufilam (PTI-125) Details Alzheimer's disease | Phase 3 Data readout |